Comparison
Why is EyePoint Pharmaceuticals, Inc. ?
- NET SALES(HY) At USD 1.32 MM has Grown at -96.35%
- OPERATING CASH FLOW(Y) Lowest at USD -267.54 MM
- ROCE(HY) Lowest at -102.71%
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 52.24%, its profits have fallen by -77.2%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is EyePoint Pharmaceuticals, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Higher at USD -152.44 MM
Highest at 1.96 times
At USD 1.32 MM has Grown at -96.35%
Lowest at USD -267.54 MM
Lowest at -102.71%
Highest at -86.88 %
Lowest at USD -84.88 MM
Lowest at USD -84.83 MM
Grown by 171.3% (YoY
Lowest at USD -86.59 MM
Lowest at USD -0.99
Here's what is working for EyePoint Pharmaceuticals, Inc.
Inventory Turnover Ratio
Here's what is not working for EyePoint Pharmaceuticals, Inc.
Net Sales (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Debt-Equity Ratio
Operating Profit (USD MM)
EPS (USD)
Raw Material Cost as a percentage of Sales






